Publicaciones en las que colabora con JOSÉ CARLOS PRADOS SALAZAR (9)

2018

  1. Formulation and in vitro evaluation of magnetoliposomes as a potential nanotool in colorectal cancer therapy

    Colloids and Surfaces B: Biointerfaces, Vol. 171, pp. 553-565

  2. Nano-engineering of biomedical prednisolone liposomes: evaluation of the cytotoxic effect on human colon carcinoma cell lines

    Journal of Pharmacy and Pharmacology, Vol. 70, Núm. 4, pp. 488-497

  3. Nanoemulsion strategy for ursolic and oleanic acids isolates from plumeria obtusa improves antioxidant and cytotoxic activity in melanoma cells

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 18, Núm. 6, pp. 847-853

2017

  1. Development and Characterization of Magnetite/Poly(butylcyanoacrylate) Nanoparticles for Magnetic Targeted Delivery of Cancer Drugs

    AAPS PharmSciTech, Vol. 18, Núm. 8, pp. 3042-3052

  2. Development of biomedical 5-fluorouracil nanoplatforms for colon cancer chemotherapy: Influence of process and formulation parameters

    International Journal of Pharmaceutics, Vol. 530, Núm. 1-2, pp. 155-164

  3. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study

    European Journal of Pharmaceutical Sciences, Vol. 102, pp. 24-34

2015

  1. Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer

    AAPS Journal, Vol. 17, Núm. 4, pp. 918-929

2013

  1. Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 85, Núm. 3 PART A, pp. 329-338

2012

  1. Doxorubicin-loaded nanoparticles: New advances in breast cancer therapy

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 12, Núm. 9, pp. 1058-1070